journal
https://read.qxmd.com/read/39111591/predicting-metformin-efficacy-in-improving-insulin-sensitivity-among-women-with-polycystic-ovary-syndrome-and-insulin-resistance-a-machine-learning-study
#21
JOURNAL ARTICLE
Jiani Fu, Yiwen Zhang, Xiaowen Cai, Yong Huang
OBJECTIVE: Metformin is clinically effective in treating polycystic ovary syndrome (PCOS) with insulin resistance (IR), while its efficacy varies among individuals. This study aims to develop a machine learning model to predict the efficacy of metformin in improving insulin sensitivity among women with PCOS and IR. METHODS: This is a retrospective analysis of a multicenter, randomized controlled trial involving 114 women diagnosed with PCOS and IR. All women received metformin treatment for 4 months...
August 5, 2024: Endocrine Practice
https://read.qxmd.com/read/39103149/clinical-review-the-approach-to-the-evaluation-and-management-of-bilateral-adrenal-masses
#22
REVIEW
Ann T Sweeney, Oksana Hamidi, Prerna Dogra, Shobana Athimulam, Ricardo Correa, Michael A Blake, Travis McKenzie, Anand Vaidya, Karel Pacak, Amir Hamrahian, Irina Bancos
No abstract text is available yet for this article.
August 3, 2024: Endocrine Practice
https://read.qxmd.com/read/39059470/recent-trends-in-diabetic-and-non-diabetic-neuropathies-a-retrospective-hospital-based-nation-wide-cohort-study
#23
JOURNAL ARTICLE
Horatiu F Coman, Adriana Rusu, Norina A Gavan, Cosmina I Bondor, Alexandru D Gavan, Cornelia G Bala
OBJECTIVE: The aim of this research was to evaluate the trends in diabetic and non-diabetic neuropathies in a hospital-based cohort between 2010 and 2019 in Romania. RESEARCH DESIGN AND METHODS: We retrospectively analyzed cases with a primary or secondary discharge ICD-10 diagnoses codes of neuropathy reported throughout Romania. RESULTS: 1,725,729 hospitalizations with a diagnosis of neuropathy (44.6% diabetic neuropathy and 55.4% nondiabetic neuropathy) were identified...
July 24, 2024: Endocrine Practice
https://read.qxmd.com/read/39066759/navigating-the-new-frontiers-of-hyperglycemic-crisis-management-unveiling-the-latest-american-diabetes-association-consensus-report
#24
JOURNAL ARTICLE
Swapnil Khare, Mihail Zilbermint, Rajesh Garg, Viral N Shah
No abstract text is available yet for this article.
July 23, 2024: Endocrine Practice
https://read.qxmd.com/read/39053588/automated-insulin-delivery-technology-in-the-hospital-update-on-safety-and-efficacy-data
#25
JOURNAL ARTICLE
Bithika Thompson, Mary E Boyle, Janna C Castro, Christopher Dodoo, Curtiss B Cook
BACKGROUND: Automated insulin delivery systems (AID) are a rapidly growing component in the area of continuous subcutaneous insulin infusion (CSII) therapy. As more patients use these systems in the outpatient setting, it is important to assess safety if their use is allowed to continue in the inpatient setting. METHODS: Analysis was conducted of the records of patients using AID technology upon admission to our hospital between June 2020 and December 2022. Adverse events and glycemic control of AID users were compared to patients using non-AID systems and to patients who had CSII discontinued...
July 23, 2024: Endocrine Practice
https://read.qxmd.com/read/39032832/is-there-a-relationship-of-cortisol-and-sex-steroid-hormones-with-mental-health-in-middle-aged-adults-the-fit-ageing-study
#26
JOURNAL ARTICLE
Lourdes Herrera-Quintana, Héctor Vázquez-Lorente, Almudena Carneiro-Barrera, Luis Gutiérrez-Rojas, Manuel J Castillo, Francisco J Amaro-Gahete
PURPOSE: Mental health has emerged as a worldwide concern given the rising incidence of anxiety and depression disorders in the last years. Cortisol and sex steroid hormones have been demonstrated to be important regulators of mental health processes in older adults. However, the evidence considering these integrated variables in apparently healthy middle-aged individuals has not been thoroughly addressed. The present study was aimed at investigating the association of plasma cortisol, testosterone, free testosterone, Sex Hormone-Binding Globulin (SHBG) and Dehydroepiandrosterone-sulfate (DHEAS) levels with mental health in middle-aged adults...
July 18, 2024: Endocrine Practice
https://read.qxmd.com/read/39032831/management-of-pancreatic-neuroendocrine-tumors-surgical-strategies-and-controversies
#27
REVIEW
Roger R Perry, Eric C Feliberti, Marybeth S Hughes
OBJECTIVE: Pancreatic neuroendocrine tumors (PNETs) are uncommon tumors which are increasing in incidence. The management of these tumors continues to evolve. This review examines the current role of surgery in the treatment of these tumors. METHODS: Studies published over the past 10 years were identified using several databases including PubMed, MEDLINE, and Science Direct. Search terms included PNETs, treatment, and surgery. Clinical practice guidelines and updates from several major groups were reviewed...
July 18, 2024: Endocrine Practice
https://read.qxmd.com/read/39023469/corrigendum-to-sodium-glucose-cotransporter-2-inhibitors-reduce-the-risk-of-hospitalization-for-heart-failure-and-amputation-rate-compared-with-incretin-based-therapy-in-patients-with-diabetic-foot-disease-a-nationwide-population-based-study-endocrine-practice
#28
https://read.qxmd.com/read/39023468/corrigendum-to-relationship-between-serum-25-hydroxyvitamin-d-and-bone-mineral-density-fracture-risk-and-bone-metabolism-in-adults-with-osteoporosis-fractures-endocrine-practice-30-7-2024-616-623
#29
Fang-Ping Chen, Yu-Ching Lin, Yu-Jr Lin, Mei-Huei Huang, Jung-Fu Chen, Po-Liang Lai, Chia-Wei Chang, Tsung-Cheng Yin
No abstract text is available yet for this article.
July 17, 2024: Endocrine Practice
https://read.qxmd.com/read/39025301/effect-of-combined-low-dose-hcg-fsh-and-testosterone-therapy-lft-regimen-versus-conventional-high-dose-hcg-and-fsh-on-spermatogenesis-and-biomarkers-in-men-with-hypogonadotropic-hypogonadism
#30
JOURNAL ARTICLE
Nikhil Singhania, Konsam Biona Devi, Japleen Kaur, Anil Bhansali, Ujjwal Gorsi, Naresh Sachdeva, Sunil Arora, Ashutosh Rai, Rama Walia
OBJECTIVE: In male Congenital hypogonadotropic hypogonadism(CHH), it was observed that lower dose human gonadotropic hormone(hCG) can maintain normal intratesticular testosterone(ITT) levels. We propose this study to compare the Low-Dose hCG, follicle stimulating hormone(FSH), and Testosterone(T) [LFT Regimen] to conventional treatment to induce virilization and fertility. DESIGN: This open-label randomized pilot study was conducted from June 2020 to December 2021...
July 16, 2024: Endocrine Practice
https://read.qxmd.com/read/39025300/the-use-of-semaglutide-in-patients-with-renal-failure-a-retrospective-cohort-study
#31
JOURNAL ARTICLE
Jane J Long, Sukhdeep S Sahi, Adley I Lemke, Jie Na, Oscar A Garcia Valencia, Pooja Budhiraja, Hani M Wadei, Vineeth Sudhindran, Roberto Benzo, Matthew M Clark, Meera Shah, David Fipps, Pavel Navratil, Ahmed A Abdelrheem, Afsana A Shaik, Dustin J Duffy, Niv Pencovich, Pankaj Shah, Yogish C Kudva, Aleksandra Kukla, Tayyab S Diwan
OBJECTIVE: Semaglutide, a glucagon-like peptide-1 receptor agonist is approved for weight loss and diabetes treatment, but limited literature exists regarding semaglutide use in patients with advanced chronic kidney disease (CKD). Therefore, this project assessed the safety and efficacy of semaglutide among patients with estimated glomerular filtration rate (eGFR) 15-29 mL/min/1.73 m2 (CKD stage 4), eGFR<15 mL/min/1.73 m2 (CKD stage 5) or on dialysis. METHODS: This is a retrospective electronic medical record based analysis of consecutive patients with advanced CKD (defined as CKD 4 or greater) who were started on semaglutide (injectable or oral)...
July 16, 2024: Endocrine Practice
https://read.qxmd.com/read/39004306/development-and-validation-of-a-prediction-model-for-thyroid-dysfunction-in-patients-during-immunotherapy
#32
JOURNAL ARTICLE
Qian Wang, Tingting Wu, Ru Zhao, Yuanqin Li, Xuetao Chen, Shanmei Shen, Xiaowen Zhang
OBJECTIVE: This study was designed to develop and validate a predictive model for assessing the risk of thyroid toxicity following treatment with immune checkpoint inhibitors (ICIs). METHODS: A retrospective analysis was conducted on a cohort of 586 patients diagnosed with malignant tumors who received programmed cell death 1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors. The patients were randomly divided into training and validation cohorts in a 7:3 ratio...
July 12, 2024: Endocrine Practice
https://read.qxmd.com/read/38992800/parenteral-estradiol-for-transgender-women-time-to-adjust-the-dose
#33
EDITORIAL
Kayla T Patel, Vin Tangpricha
No abstract text is available yet for this article.
July 9, 2024: Endocrine Practice
https://read.qxmd.com/read/38992799/expert-opinion-review-utilizing-somapacitan-a-long-acting-growth-hormone-formulation-for-the-treatment-of-adult-growth-hormone-deficiency-a-guide-for-the-clinician
#34
REVIEW
Kevin C J Yuen
OBJECTIVE: Somapacitan is the first approved and currently the only long-acting GH (LAGH) formulation in the United States for treatment of adults with growth hormone deficiency (GHD). The aim of this review was to provide a practical approach for clinicians on how to utilize somapacitan in the treatment of adults with GHD. METHODS: Literature search was performed on PubMed using key words, including adult growth hormone deficiency, long-acting growth hormone, somapacitan, treatment and management...
July 9, 2024: Endocrine Practice
https://read.qxmd.com/read/38992798/letter-to-the-editor-endocrine-practice-the-role-of-teplizumab-in-newly-diagnosed-type-1-diabetes
#35
LETTER
David S H Bell, Terri Jerkins
No abstract text is available yet for this article.
July 9, 2024: Endocrine Practice
https://read.qxmd.com/read/38992797/reply-to-the-letter-to-the-editor-endocrine-practice-for-role-of-teplizumab-a-humanized-anti-cd3-monoclonal-antibody-in-managing-newly-diagnosed-type-1-diabetes-an-updated-systematic-review-and-meta-analysis
#36
LETTER
Lakshmi Nagendra, Deep Dutta, Sunetra Mondal, Ashmita Yadav, Fatema Tuz Zahura Aalpona, A B M Kamrul-Hasan
No abstract text is available yet for this article.
July 9, 2024: Endocrine Practice
https://read.qxmd.com/read/38992796/effects-of-physical-activity-on-blood-lipids-and-hba1c-in-healthy-pregnant-women-the-fitmum-randomized-controlled-trial
#37
JOURNAL ARTICLE
Ida Karoline Bach Jensen, Caroline Borup Roland, Signe de Place Knudsen, Anne Dsane Jessen, Saud Abdulaziz Alomairah, Ole H Mortensen, Lennart J Friis-Hansen, Jane M Bendix, Stig Molsted, Bente Stallknecht, Tine D Clausen, Ellen Løkkegaard
OBJECTIVE: Maternal blood lipid and glucose concentrations during pregnancy affect fetal growth and the risk of pregnancy and delivery complications. We aimed to investigate the effects of physical activity (PA) during pregnancy on maternal blood lipid and hemoglobin A1c (HbA1c) concentrations. We hypothesized that higher PA was associated with improved lipid profile and glycemic control. METHODS: In a secondary analysis of a randomized controlled trial, we included 216 pregnant women before week 15+0 and tested the effects of two different PA interventions throughout pregnancy compared to standard care on maternal blood lipid and HbA1c concentrations...
July 9, 2024: Endocrine Practice
https://read.qxmd.com/read/38969009/risk-stratification-intention-to-fast-and-outcomes-of-fast-during-ramadan-in-people-with-diabetes-presenting-to-tertiary-care-hospital
#38
JOURNAL ARTICLE
Suleman Elahi Malik, Shaista Kanwal, Iqbal Haider, Yasir Iqbal, Hammad Naeem, Zabia Jehandad, Javeria Javed, Syeda Adan Shah
OBJECTIVES: The objective of this study was to evaluate the stratification of people with diabetes mellitus (DM) based on the International Diabetes Federation Diabetes and Ramadan (IDF DAR) 2021 risk calculator into different risk categories, and to assess their intentions to fast and outcomes of fast during the holy month of Ramadan. RESEARCH DESIGN AND METHODS: This was a 3-month prospective study which was carried out from 9th February to 6th of May 2023 (6 weeks before Ramadan till 6 weeks after Ramadan) at a tertiary care hospital in Pakistan...
July 3, 2024: Endocrine Practice
https://read.qxmd.com/read/38936546/impact-of-teprotumumab-on-clinical-practice-in-thyroid-eye-disease
#39
JOURNAL ARTICLE
Kharisa N Rachmasari, David Toro-Tobon, Lilly H Wagner, Andrea A Tooley, Elizabeth A Bradley, Marius N Stan
BACKGROUND: Following its Food and Drug Administration approval in January 2020, we examined the impact of teprotumumab on thyroid eye disease (TED) clinical practices. METHODS: Across 3 referral centers from January 1, 2018, to December 30, 2022, we retrospectively analyzed demographics, clinical features, treatment choices, and insurance status of patients with active, moderate to severe TED. RESULTS: Of 74 patients recommended for medical therapy, 53% received collaborative recommendations from endocrinologists and ophthalmologists in a TED clinic...
June 25, 2024: Endocrine Practice
https://read.qxmd.com/read/38934984/corrigendum-to-paraganglioma-of-the-head-and-neck-a-review-endocrine-practice-29-2-2023-pages-141-147
#40
Lyndsey Sandow, Rajat Thawani, Myung Sun Kim, Michael C Heinrich
No abstract text is available yet for this article.
June 25, 2024: Endocrine Practice
journal
journal
32527
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.